Researchers propose 'pseudo leukotrienes' as key players in asthma, shifting focus from traditional leukotrienes, potentially transforming treatment approaches. The post Decades-old asthma theory challenged: Newly discovered molecules may be real drivers of disease first appeared on Scientific Inquirer.
